Calian sells U.S. IT business to Trace3
Analysis based on 17 articles · First reported Aug 26, 2026 · Last updated Aug 27, 2026
The divestiture is expected to provide Calian with approximately CAD $43 million in cash, strengthening its balance sheet and funding growth initiatives in higher-margin sectors. The sale may modestly reduce Calian's revenue but improve its margin profile, while Trace3 expands its U.S. footprint in enterprise IT solutions.
Calian Group Ltd. (TSX: CGY), a mission-critical solutions company, announced on August 26, 2026, that it has entered into a definitive agreement to sell its U.S. commercial IT business based in Houston, Texas, to Trace3, a technology solutions provider headquartered in Irvine, California. The transaction provides upfront cash proceeds of approximately CAD $43 million (US $31 million) and the assumption of certain net liabilities totaling approximately CAD $17 million (US $12 million) by the purchaser. The sale is expected to close in Calian's fourth fiscal quarter, subject to customary closing conditions. The divestiture aligns with Calian's strategy to focus on high-growth, high-margin opportunities in defence, space, healthcare, and nuclear sectors across Canada, the U.S., the U.K., and Europe. Proceeds will be directed toward organic growth and M&A in core verticals. Calian generated a mid-teen IRR over its five years of ownership of the business. Patrick Houston, President and CEO of Calian, stated that the transaction allows the company to sharpen its strategic focus and redeploy capital to markets with the strongest competitive position.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard